2.05 USD
-0.03 (-1.44%)
SHLT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. The financial health of SHLT is average, but there are quite some concerns on its profitability. SHLT does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- SHLT had negative earnings in the past year.
- In the past year SHLT had a positive cash flow from operations.
- In multiple years SHLT reported negative net income over the last 5 years.
- The reported operating cash flow has been mixed in the past 5 years: SHLT reported negative operating cash flow in multiple years.
1.2 Ratios
- With a Return On Assets value of -8.60%, SHLT is not doing good in the industry: 71.96% of the companies in the same industry are doing better.
- SHLT has a Return On Equity of -13.13%. This is in the lower half of the industry: SHLT underperforms 62.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.6% | ||
| ROE | -13.13% | ||
| ROIC | N/A |
ROA(3y)-5.73%
ROA(5y)-1.45%
ROE(3y)-11.52%
ROE(5y)-3.49%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- SHLT has a Gross Margin of 45.73%. This is in the better half of the industry: SHLT outperforms 73.83% of its industry peers.
- In the last couple of years the Gross Margin of SHLT has declined.
- SHLT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 45.73% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-6.47%
2. Health
2.1 Basic Checks
- SHLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for SHLT has been increased compared to 1 year ago.
- Compared to 1 year ago, SHLT has an improved debt to assets ratio.
2.2 Solvency
- SHLT has an Altman-Z score of -0.08. This is a bad value and indicates that SHLT is not financially healthy and even has some risk of bankruptcy.
- SHLT's Altman-Z score of -0.08 is on the low side compared to the rest of the industry. SHLT is outperformed by 76.64% of its industry peers.
- A Debt/Equity ratio of 0.20 indicates that SHLT is not too dependend on debt financing.
- With a decent Debt to Equity ratio value of 0.20, SHLT is doing good in the industry, outperforming 69.16% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.08 |
ROIC/WACCN/A
WACC7.08%
2.3 Liquidity
- A Current Ratio of 2.17 indicates that SHLT has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 2.17, SHLT is in the better half of the industry, outperforming 76.64% of the companies in the same industry.
- SHLT has a Quick Ratio of 1.98. This is a normal value and indicates that SHLT is financially healthy and should not expect problems in meeting its short term obligations.
- The Quick ratio of SHLT (1.98) is better than 74.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.17 | ||
| Quick Ratio | 1.98 |
3. Growth
3.1 Past
- SHLT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -282.35%.
- The Revenue has decreased by -2.04% in the past year.
- Measured over the past years, SHLT shows a small growth in Revenue. The Revenue has been growing by 3.16% on average per year.
EPS 1Y (TTM)-282.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.41%
Revenue 1Y (TTM)-2.04%
Revenue growth 3Y12.43%
Revenue growth 5Y3.16%
Sales Q2Q%-3.92%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for SHLT. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- No dividends for SHLT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SHL TELEMEDICINE LTD-ADR / SHLT FAQ
Can you provide the ChartMill fundamental rating for SHL TELEMEDICINE LTD-ADR?
ChartMill assigns a fundamental rating of 2 / 10 to SHLT.
What is the valuation status of SHL TELEMEDICINE LTD-ADR (SHLT) stock?
ChartMill assigns a valuation rating of 0 / 10 to SHL TELEMEDICINE LTD-ADR (SHLT). This can be considered as Overvalued.
What is the profitability of SHLT stock?
SHL TELEMEDICINE LTD-ADR (SHLT) has a profitability rating of 1 / 10.
Can you provide the financial health for SHLT stock?
The financial health rating of SHL TELEMEDICINE LTD-ADR (SHLT) is 4 / 10.